UC San Diego — La Jolla, California

Public research footprint of UC San Diego, compiled from the ClinicalTrials.gov public registry.

706

Registered studies

333

Active

142

Recruiting now

250

Completed

Stopped or withdrawn

Most-studied conditions

Stage IIIB Lung Cancer AJCC v8 · Acute Lymphoblastic Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Stage IIIA Lung Cancer AJCC v8

Recently updated registry entries

NCT06632977 — Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT05432804 — Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UC San Diego?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.